Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com
A15725 | Pages: 240 | Charts: 67 | Tables: 206 |
The global clinical trial packaging market size was valued at $2.58 billion in 2021, and is projected to reach $6.21 billion by 2031, growing at a CAGR of 9.1% from 2022 to 2031.
The type of packaging used for the clinical trial generally consists of the primary containers that are generally blisters and vials with a secondary packaging over it that is composed of a carton and a label. The demand for clinical trial packaging industryis growing due to the technological developments in the medical device industry that is leading to increase its usage for the pharmaceutical applications.
In addition, the demand for innovative packaging solutions are growing that is leading to adoption of environmentally friendly packaging material that is more ecofriendly and could be recycled easily. Such factor are driving the clinical trial packaging market growth. However, strict rules and regulations by the government across the world is a factor limiting the growth of clinical trial packaging market due to restrictions in usage of certain packaging materials such as plastic.
[PACKAGINGTYPEGRAPH]
Furthermore, during the outbreak of the COVID-19 pandemic, construction, manufacturing, hotel, and tourism industries were majorly affected. Manufacturing activities were halted or restricted. Construction and transportation activities, along with their supply chains, were hampered on a global level. This led to decline in manufacturing of clinical trial packaging as well as their demand in the market, thereby restraining the growth of the clinical trial packaging market share. Conversely, industries are gradually resuming their regular manufacturing and services. This is expected to lead to re-initiation of clinical trial packaging companies at their full-scale capacities, that helped the market to recover by end of 2021.
[MATERIALGRAPH]
On the contrary, technological advancements over the packaging method is leading to new form of packaging systems that is more user friendly. Thus, such a factor is expected to offers new opportunities for the growth of the clinical trial packaging market.
[ENDUSERGRAPH]
The clinical trial packaging market is segmented into Packaging Type, Material and End-user. On the basis of packaging type, it is further classified into syringes, vials & ampoules, bottles, bags & pouches and others. By material, it is divided into plastic, glass, metal, paper, and corrugated fiber. By end user, it is categorized into research laboratories, clinical research organizations, and drug manufacturing facilities. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
On the basis of packaging type, in 2021 the bags & pouches segment dominated the market, in terms of revenue, whereas the others segment is expected to witness growth at the highest CAGR during the forecast period. As per material, in 2021, the plastic segment led the clinical trial packaging market, and the metal segment expected to exhibit highest CAGR in the near future. By end user, the research laboratories segment led the market in 2021, in terms of revenue and the drug manufacturing facilities segment is anticipated to register highest CAGR during the forecast period. Region wise, North America garnered the highest revenue in 2021; however, Asia-Pacific is anticipated to register highest CAGR during the forecast period.
[REGIONGRAPH]
The major players profiled in the global clinical trial packaging market include, Almac Group Limited, 3M Company, Bilcare Limited, Corden Pharma International, Thermo Fisher Scientific Inc., Mawdsley-Brooks & Co. Ltd., Parexel International Corporation, Piramal Enterprises Ltd., Sharp Services, LLC, Caligor Coghlan, Next Pharma Technologies Holding Limited, PCI Pharma Services, Sentry BioPharma Services, Westrock Company, Körber Medipak Systems AG, WuXi AppTec, and Xerimis Inc. Major companies in the market have adopted product launch, partnership, business expansion, and acquisition as their key developmental strategies to offer better products and services to customers in the market.
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the clinical trial packaging market analysis from 2021 to 2031 to identify the prevailing clinical trial packaging market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Key Market Segments
Key Market Players
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Research methodology
1.2.1.Primary research
1.2.2.Secondary research
1.2.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top investment factors
3.2.3.Parent Market Analysis
3.3.Key forces shaping digital showers industry
3.4.PESTEL Analysis
3.4.1.Political
3.4.2.Economic
3.4.3.Socio-Culture
3.4.4.Technology
3.4.5.Environment
3.4.6.Legal
3.5.Value chain analysis
3.6.Smiling curve value chain model
3.7.Product life-cycle analysis
3.8.Market dynamics
3.8.1.Drivers
3.8.1.1.Technological developments in medical device industry
3.8.2.Restraint
3.8.2.1.Strict rules & regulations imposed by governments across the world
3.8.3.Opportunity
3.8.3.1.Technological advancements
3.9.COVID-19 impact analysis
CHAPTER 4:CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE
4.1.Market overview
4.1.1.Market size and forecast, by packaging type
4.2.Syringes
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Vials & Ampoules
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.4.Bottles
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
4.5.Bags & Pouches
4.5.1.Market size and forecast, by region
4.5.2.Market analysis, by country
4.6.Others
4.6.1.Key market trends, growth factors, and opportunities
4.6.2.Market size and forecast, by region
4.6.3.Market analysis, by country
CHAPTER 5:CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL
5.1.Market overvie
5.1.1.Market size and forecast, by material
5.2.Plastic
5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market analysis, by country
5.2.4.Market analysis, by packaging type
5.2.4.1.Market size and forecast, for bottles, by end user
5.3.Glass
5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market analysis, by country
5.4.Metal
5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by region
5.4.3.Market analysis, by country
5.5.Paper
5.5.1.Key market trends, growth factors, and opportunities
5.5.2.Market size and forecast, by region
5.5.3.Market analysis, by country
5.6.Corrugated Fiber
5.6.1.Key market trends, growth factors, and opportunities
5.6.2.Market size and forecast, by region
5.6.3.Market analysis, by country
CHAPTER 6:CLINICAL TRIAL PACKAGING MARKET, BY END USER
6.1.Market overview
6.1.1.Market size and forecast, by end user
6.2.Research Laboratories
6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by region
6.2.3.Market analysis, by country
6.3.Clinical Research Organizations
6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by region
6.3.3.Market analysis, by country
6.4.Drug Manufacturing Facilities
6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by region
6.4.3.Market analysis, by country
CHAPTER 7:CLINICAL TRIAL PACKAGING MARKET, BY REGION
7.1.Market overview
7.1.1.Market size and forecast, by region
7.2.North America
7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by packaging type
7.2.3.Market size and forecast, by material
7.2.4.Market size and forecast, by end user
7.2.5.Market size and forecast, by country
7.2.5.1.U.S.
7.2.5.1.1.Market size and forecast, by packaging type
7.2.5.1.2.Market size and forecast, by material
7.2.5.1.3.Market size and forecast, by end user
7.2.5.2.Canada
7.2.5.2.1.Market size and forecast, by packaging type
7.2.5.2.2.Market size and forecast, by material
7.2.5.2.3.Market size and forecast, by end user
7.2.5.3.Mexico
7.2.5.3.1.Market size and forecast, by packaging type
7.2.5.3.2.Market size and forecast, by material
7.2.5.3.3.Market size and forecast, by end user
7.3.Europe
7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by packaging type
7.3.3.Market size and forecast, by material
7.3.4.Market size and forecast, by end user
7.3.5.Market size and forecast, by country
7.3.5.1.Germany
7.3.5.1.1.Market size and forecast, by packaging type
7.3.5.1.2.Market size and forecast, by material
7.3.5.1.3.Market size and forecast, by end user
7.3.5.2.France
7.3.5.2.1.Market size and forecast, by packaging type
7.3.5.2.2.Market size and forecast, by material
7.3.5.2.3.Market size and forecast, by end user
7.3.5.3.UK
7.3.5.3.1.Market size and forecast, by packaging type
7.3.5.3.2.Market size and forecast, by material
7.3.5.3.3.Market size and forecast, by end user
7.3.5.4.Italy
7.3.5.4.1.Market size and forecast, by packaging type
7.3.5.4.2.Market size and forecast, by material
7.3.5.4.3.Market size and forecast, by end user
7.3.5.5.Rest of Europe
7.3.5.5.1.Market size and forecast, by packaging type
7.3.5.5.2.Market size and forecast, by material
7.3.5.5.3.Market size and forecast, by end user
7.4.Asia-Pacific
7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by packaging type
7.4.3.Market size and forecast, by material
7.4.4.Market size and forecast, by end user
7.4.5.Market size and forecast, by country
7.4.5.1.China
7.4.5.1.1.Market size and forecast, by packaging type
7.4.5.1.2.Market size and forecast, by material
7.4.5.1.3.Market size and forecast, by end user
7.4.5.2.Japan
7.4.5.2.1.Market size and forecast, by packaging type
7.4.5.2.2.Market size and forecast, by material
7.4.5.2.3.Market size and forecast, by end user
7.4.5.3.South Korea
7.4.5.3.1.Market size and forecast, by packaging type
7.4.5.3.2.Market size and forecast, by material
7.4.5.3.3.Market size and forecast, by end user
7.4.5.4.India
7.4.5.4.1.Market size and forecast, by packaging type
7.4.5.4.2.Market size and forecast, by material
7.4.5.4.3.Market size and forecast, by end user
7.4.5.5.Rest of Asia-Pacific
7.4.5.5.1.Market size and forecast, by packaging type
7.4.5.5.2.Market size and forecast, by material
7.4.5.5.3.Market size and forecast, by end user
7.5.LAMEA
7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by packaging type
7.5.3.Market size and forecast, by material
7.5.4.Market size and forecast, by end user
7.5.5.Market size and forecast, by country
7.5.5.1.Latin America
7.5.5.1.1.Market size and forecast, by packaging type
7.5.5.1.2.Market size and forecast, by material
7.5.5.1.3.Market size and forecast, by end user
7.5.5.2.Middle East
7.5.5.2.1.Market size and forecast, by packaging type
7.5.5.2.2.Market size and forecast, by material
7.5.5.2.3.Market size and forecast, by end user
7.5.5.3.Africa
7.5.5.3.1.Market size and forecast, by packaging type
7.5.5.3.2.Market size and forecast, by material
7.5.5.3.3.Market size and forecast, by end user
CHAPTER 8:COMPETITIVE LANDSCAPE
8.1.Introduction
8.1.1.Market player positioning
8.2.Top winning strategies
8.2.1.Top winning strategies, by year
8.2.2.Top winning strategies, by development
8.2.3.Top winning strategies, by company
8.2.4.Company Snapshots
CHAPTER 9:COMPANY PROFILES
9.1.3M COMPANY
9.1.1.Company overview
9.1.2.Key executives
9.1.3.Company snapshot
9.1.4.Operating business segments
9.1.5.R&D expenditure
9.1.6.Business performance
9.1.7.Key strategic moves and developments
9.2.ALMAC GROUP LIMITED
9.2.1.Almac Group Ltd.: Company overview
9.2.2.Key executives
9.2.3.Company snapshot
9.2.4.Almac Group Ltd.: Operating business category
9.2.5.Key strategic moves and developments
9.3.BILCARE LIMITED
9.3.1.Company overview
9.3.2.Key executives
9.3.3.Company snapshot
9.3.4.Product portfolio
9.3.5.R&D expenditure
9.3.6.Business performance
9.4.CALIGOR COGHLAN
9.4.1.Company overview
9.4.2.Key executives
9.4.3.Company snapshot
9.4.4.Product portfolio
9.4.5.Key strategic moves and developments
9.5.CORDEN PHARMA INTERNATIONAL
9.5.1.Company overview
9.5.2.Key executives
9.5.3.Company snapshot
9.5.4.Operating business categories
9.5.5.Key strategic moves and developments
9.6.KÖRBER MEDIPAK SYSTEMS AG
9.6.1.Company overview
9.6.2.Key executives
9.6.3.Company Snapshot-
9.6.4.Operating Business Category
9.6.5.Key strategic moves and developments
9.7.MAWDSLEY-BROOKS & CO. LTD.
9.7.1.Company overview
9.7.2.Key executives
9.7.3.Company snapshot
9.7.4.Operating business categories
9.7.5.Key strategic moves and developments
9.8.NEXT PHARMA TECHNOLOGIES HOLDING LIMITED
9.8.1.Company overview-
9.8.2.Key executives
9.8.3.Company snapshot-
9.8.4.Operating business categories
9.8.5.Key Strategies and Developments
9.9.PAREXEL INTERNATIONAL CORPORATION
9.9.1.Company overview
9.9.2.Key executives
9.9.3.Company snapshot
9.9.4.Product portfolio
9.9.5.Key strategic moves and developments.
9.10.PCI PHARMA SERVICES
9.10.1.Company overview
9.10.2.Key executives
9.10.3.Operating business categories
9.10.4.Key strategic moves and developments
9.11.PIRAMAL ENTERPRISES LTD.
9.11.1.Company overview
9.11.2.Key executives
9.11.3.Company snapshot
9.11.4.Operating business segments
9.11.5.Business performance
9.11.6.Key strategic moves and developments
9.12.SENTRY BIOPHARMA SERVICES
9.12.1.Company overview
9.12.2.Key executives
9.12.3.Company snapshot
9.12.4.Product portfolio
9.13.SHARP SERVICES, LLC
9.13.1.Company overview
9.13.2.Key executives
9.13.3.Company snapshot
9.13.4.Operating business Categories
9.13.5.Product portfolio
9.13.6.Key strategic moves and developments
9.14.THERMO FISHER SCIENTIFIC INC.
9.14.1.Company overview
9.14.2.Company snapshot
9.14.3.Operating business segments
9.14.4.Product portfolio
9.14.5.Business performance
9.14.6.Key strategic moves and developments
9.15.WESTROCK COMPANY
9.15.1.Company overview
9.15.2.Key executives
9.15.3.Company snapshot
9.15.4.Operating business category
9.15.5.Key strategic moves and developments
CHAPTER 10:KEY INNOVATORS
10.1.WUXI APPTEC
10.1.1.Company overview
10.1.2.Key executives
10.1.3.Company snapshot
10.1.4.Operating business category
10.1.5.Key strategic moves and developments
10.1.6.AMR Perspective: WuXi Apptec and its Impact on the Market
10.2.XERIMIS INC
10.2.1.Company overview
10.2.2.Key executives
10.2.3.Company snapshot
10.2.4.Operating business category
10.2.5.Key strategic moves and developments
10.2.6.AMR Perspective: Xerimis Inc. and its Impact on the Market
LIST OF TABLES
TABLE 01.CLINICAL TRIAL PACKAGING MARKET REVENUE, BY PACKAGING TYPE, 2021–2031 ($ MILLION)
TABLE 02.CLINICAL TRIAL PACKAGING MARKET REVENUE FOR SYRINGES, BY REGION, 2021–2031 ($ MILLION)
TABLE 03.NORTH AMERICA CLINICAL TRIAL PACKAGING MARKET REVENUE FOR SYRINGES, BY REGION, 2021–2031 ($ MILLION)
TABLE 04.EUROPE CLINICAL TRIAL PACKAGING MARKET REVENUE FOR SYRINGES, BY REGION, 2021–2031 ($ MILLION)
TABLE 05.ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET REVENUE FOR SYRINGES, BY REGION, 2021–2031 ($ MILLION)
TABLE 06.LAMEA CLINICAL TRIAL PACKAGING MARKET REVENUE FOR SYRINGES, BY REGION, 2021–2031 ($ MILLION)
TABLE 07.CLINICAL TRIAL PACKAGING MARKET REVENUE FOR VIALS & AMPOULES, BY REGION, 2021–2031 ($ MILLION)
TABLE 08.NORTH AMERICA CLINICAL TRIAL PACKAGING MARKET REVENUE FOR VIALS & AMPOULES, BY REGION, 2021–2031 ($ MILLION)
TABLE 09.EUROPE CLINICAL TRIAL PACKAGING MARKET REVENUE FOR VIALS & AMPOULES, BY REGION, 2021–2031 ($ MILLION)
TABLE 10.ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET REVENUE FOR VIALS & AMPOULES, BY REGION, 2021–2031 ($ MILLION)
TABLE 11.LAMEA CLINICAL TRIAL PACKAGING MARKET REVENUE FOR VIALS & AMPOULES, BY REGION, 2021–2031 ($ MILLION)
TABLE 12.CLINICAL TRIAL PACKAGING MARKET REVENUE FOR BOTTLES, BY REGION, 2021–2031 ($ MILLION)
TABLE 13.NORTH AMERICA CLINICAL TRIAL PACKAGING MARKET REVENUE FOR BOTTLES, BY REGION, 2021–2031 ($ MILLION)
TABLE 14.EUROPE CLINICAL TRIAL PACKAGING MARKET REVENUE FOR BOTTLES, BY REGION, 2021–2031 ($ MILLION)
TABLE 15.ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET REVENUE FOR BOTTLES, BY REGION, 2021–2031 ($ MILLION)
TABLE 16.LAMEA CLINICAL TRIAL PACKAGING MARKET REVENUE FOR BOTTLES, BY REGION, 2021–2031 ($ MILLION)
TABLE 17.CLINICAL TRIAL PACKAGING MARKET REVENUE FOR BAGS & POUCHES, BY REGION, 2021–2031 ($ MILLION)
TABLE 18.NORTH AMERICA CLINICAL TRIAL PACKAGING MARKET REVENUE FOR BAGS & POUCHES, BY REGION, 2021–2031 ($ MILLION)
TABLE 19.EUROPE CLINICAL TRIAL PACKAGING MARKET REVENUE FOR BAGS & POUCHES, BY REGION, 2021–2031 ($ MILLION)
TABLE 20.ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET REVENUE FOR BAGS & POUCHES, BY REGION, 2021–2031 ($ MILLION)
TABLE 21.LAMEA CLINICAL TRIAL PACKAGING MARKET REVENUE FOR BAGS & POUCHES, BY REGION, 2021–2031 ($ MILLION)
TABLE 22.CLINICAL TRIAL PACKAGING MARKET REVENUE FOR OTHERS, BY REGION, 2021–2031 ($ MILLION)
TABLE 23.NORTH AMERICA CLINICAL TRIAL PACKAGING MARKET REVENUE FOR OTHERS, BY REGION, 2021–2031 ($ MILLION)
TABLE 24.EUROPE CLINICAL TRIAL PACKAGING MARKET REVENUE FOR OTHERS, BY REGION, 2021–2031 ($ MILLION)
TABLE 25.ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET REVENUE FOR OTHERS, BY REGION, 2021–2031 ($ MILLION)
TABLE 26.LAMEA CLINICAL TRIAL PACKAGING MARKET REVENUE FOR OTHERS, BY REGION, 2021–2031 ($ MILLION)
TABLE 27.CLINICAL TRIAL PACKAGING MARKET REVENUE, BY MATERIAL, 2021–2031 ($ MILLION)
TABLE 28.CLINICAL TRIAL PACKAGING MARKET REVENUE FOR PLASTIC, BY REGION, 2021–2031 ($ MILLION)
TABLE 29.NORTH AMERICA CLINICAL TRIAL PACKAGING MARKET REVENUE FOR PLASTIC, BY REGION, 2021–2031 ($ MILLION)
TABLE 30.EUROPE CLINICAL TRIAL PACKAGING MARKET REVENUE FOR PLASTIC, BY REGION, 2021–2031 ($ MILLION)
TABLE 31.ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET REVENUE FOR PLASTIC, BY REGION, 2021–2031 ($ MILLION)
TABLE 32.LAMEA CLINICAL TRIAL PACKAGING MARKET REVENUE FOR PLASTIC, BY REGION, 2021–2031 ($ MILLION)
TABLE 33.CLINICAL TRIAL PACKAGING MARKET REVENUE FOR PLASTIC, BY PACKAGING TYPE, 2021–2031 ($ MILLION)
TABLE 34.CLINICAL TRIAL PACKAGING MARKET REVENUE FOR BOTTLES, BY END USER, 2021–2031 ($ MILLION)
TABLE 35.CLINICAL TRIAL PACKAGING MARKET REVENUE FOR GLASS, BY REGION, 2021–2031 ($ MILLION)
TABLE 36.NORTH AMERICA CLINICAL TRIAL PACKAGING MARKET REVENUE FOR GLASS, BY REGION, 2021–2031 ($ MILLION)
TABLE 37.EUROPE CLINICAL TRIAL PACKAGING MARKET REVENUE FOR GLASS, BY REGION, 2021–2031 ($ MILLION)
TABLE 38.ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET REVENUE FOR GLASS, BY REGION, 2021–2031 ($ MILLION)
TABLE 39.LAMEA CLINICAL TRIAL PACKAGING MARKET REVENUE FOR GLASS, BY REGION, 2021–2031 ($ MILLION)
TABLE 40.CLINICAL TRIAL PACKAGING MARKET REVENUE FOR METAL, BY REGION, 2021–2031 ($ MILLION)
TABLE 41.NORTH AMERICA CLINICAL TRIAL PACKAGING MARKET REVENUE FOR METAL, BY REGION, 2021–2031 ($ MILLION)
TABLE 42.EUROPE CLINICAL TRIAL PACKAGING MARKET REVENUE FOR METAL, BY REGION, 2021–2031 ($ MILLION)
TABLE 43.ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET REVENUE FOR METAL, BY REGION, 2021–2031 ($ MILLION)
TABLE 44.LAMEA CLINICAL TRIAL PACKAGING MARKET REVENUE FOR METAL, BY REGION, 2021–2031 ($ MILLION)
TABLE 45.CLINICAL TRIAL PACKAGING MARKET REVENUE FOR PAPER, BY REGION, 2021–2031 ($ MILLION)
TABLE 46.NORTH AMERICA CLINICAL TRIAL PACKAGING MARKET REVENUE FOR PAPER, BY REGION, 2021–2031 ($ MILLION)
TABLE 47.EUROPE CLINICAL TRIAL PACKAGING MARKET REVENUE FOR PAPER, BY REGION, 2021–2031 ($ MILLION)
TABLE 48.ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET REVENUE FOR PAPER, BY REGION, 2021–2031 ($ MILLION)
TABLE 49.LAMEA CLINICAL TRIAL PACKAGING MARKET REVENUE FOR PAPER, BY REGION, 2021–2031 ($ MILLION)
TABLE 50.CLINICAL TRIAL PACKAGING MARKET REVENUE FOR CORRUGATED FIBER, BY REGION, 2021–2031 ($ MILLION)
TABLE 51.NORTH AMERICA CLINICAL TRIAL PACKAGING MARKET REVENUE FOR CORRUGATED FIBER, BY REGION, 2021–2031 ($ MILLION)
TABLE 52.EUROPE CLINICAL TRIAL PACKAGING MARKET REVENUE FOR CORRUGATED FIBER, BY REGION, 2021–2031 ($ MILLION)
TABLE 53.ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET REVENUE FOR CORRUGATED FIBER, BY REGION, 2021–2031 ($ MILLION)
TABLE 54.LAMEA CLINICAL TRIAL PACKAGING MARKET REVENUE FOR CORRUGATED FIBER, BY REGION, 2021–2031 ($ MILLION)
TABLE 55.CLINICAL TRIAL PACKAGING MARKET REVENUE, BY END USER, 2021–2031 ($ MILLION)
TABLE 56.CLINICAL TRIAL PACKAGING MARKET REVENUE FOR RESEARCH LABORATORIES, BY REGION, 2021–2031 ($ MILLION)
TABLE 57.NORTH AMERICA CLINICAL TRIAL PACKAGING MARKET REVENUE FOR RESEARCH LABORATORIES, BY REGION, 2021–2031 ($ MILLION)
TABLE 58.EUROPE CLINICAL TRIAL PACKAGING MARKET REVENUE FOR RESEARCH LABORATORIES, BY REGION, 2021–2031 ($ MILLION)
TABLE 59.ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET REVENUE FOR RESEARCH LABORATORIES, BY REGION, 2021–2031 ($ MILLION)
TABLE 60.LAMEA CLINICAL TRIAL PACKAGING MARKET REVENUE FOR RESEARCH LABORATORIES, BY REGION, 2021–2031 ($ MILLION)
TABLE 61.CLINICAL TRIAL PACKAGING MARKET REVENUE FOR CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2021–2031 ($MILLION)
TABLE 62.NORTH AMERICA CLINICAL TRIAL PACKAGING MARKET REVENUE FOR RESEARCH ORGANIZATIONS, BY REGION, 2021–2031 ($ MILLION)
TABLE 63.EUROPE CLINICAL TRIAL PACKAGING MARKET REVENUE FOR RESEARCH ORGANIZATIONS, BY REGION, 2021–2031 ($ MILLION)
TABLE 64.ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET REVENUE FOR RESEARCH ORGANIZATIONS, BY REGION, 2021–2031 ($ MILLION)
TABLE 65.LAMEA CLINICAL TRIAL PACKAGING MARKET REVENUE FOR RESEARCH ORGANIZATIONS, BY REGION, 2021–2031 ($ MILLION)
TABLE 66.CLINICAL TRIAL PACKAGING MARKET REVENUE FOR DRUG MANUFACTURING FACILITIES, BY REGION, 2021–2031 ($MILLION)
TABLE 67.NORTH AMERICA CLINICAL TRIAL PACKAGING MARKET REVENUE FOR DRUG MANUFACTURING FACILITIES, BY REGION, 2021–2031 ($ MILLION)
TABLE 68.EUROPE CLINICAL TRIAL PACKAGING MARKET REVENUE FOR DRUG MANUFACTURING FACILITIES, BY REGION, 2021–2031 ($ MILLION)
TABLE 69.ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET REVENUE FOR DRUG MANUFACTURING FACILITIES, BY REGION, 2021–2031 ($ MILLION)
TABLE 70.LAMEA CLINICAL TRIAL PACKAGING MARKET REVENUE FOR DRUG MANUFACTURING FACILITIES, BY REGION, 2021–2031 ($ MILLION)
TABLE 71.CLINICAL TRIAL PACKAGING MARKET, BY REGION, 2021–2031 ($ MILLION)
TABLE 72.NORTH AMERICA CLINICAL TRIAL PACKAGING MARKET, BY TYPE, 2021–2031 ($ MILLION)
TABLE 73.NORTH AMERICA CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL, 2021–2031 ($ MILLION)
TABLE 74.NORTH AMERICA CLINICAL TRIAL PACKAGING MARKET, BY END USER, 2021–2031 ($ MILLION)
TABLE 75.NORTH AMERICA CLINICAL TRIAL PACKAGING MARKET, BY COUNTRY, 2021–2031 ($ MILLION)
TABLE 76.U.S. CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE, 2021–2031 ($ MILLION)
TABLE 77.U.S. CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL, 2021–2031 ($ MILLION)
TABLE 78.U.S. CLINICAL TRIAL PACKAGING MARKET, BY END USER, 2021–2031 ($ MILLION)
TABLE 79.CANADA CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE, 2021–2031 ($ MILLION)
TABLE 80.CANADA CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL 2021–2031 ($ MILLION)
TABLE 81.CANADA CLINICAL TRIAL PACKAGING MARKET, BY END USER, 2021–2031 ($ MILLION)
TABLE 82.MEXICO CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE, 2021–2031 ($ MILLION)
TABLE 83.MEXICO CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL, 2021–2031 ($ MILLION)
TABLE 84.MEXICO CLINICAL TRIAL PACKAGING MARKET, BY END USER, 2021–2031 ($ MILLION)
TABLE 85.EUROPE CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE, 2021–2031 ($ MILLION)
TABLE 86.EUROPE CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL, 2021–2031 ($ MILLION)
TABLE 87.EUROPE CLINICAL TRIAL PACKAGING MARKET, BY END USER, 2021–2031 ($ MILLION)
TABLE 88.EUROPE CLINICAL TRIAL PACKAGING MARKET, BY COUNTRY, 2021–2031 ($ MILLION)
TABLE 89.GERMANY CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE, 2021–2031 ($ MILLION)
TABLE 90.GERMANY CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL, 2021–2031 ($ MILLION)
TABLE 91.GERMANY CLINICAL TRIAL PACKAGING MARKET, BY END USER, 2021–2031 ($ MILLION)
TABLE 92.FRANCE CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE, 2021–2031 ($ MILLION)
TABLE 93.FRANCE CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL, 2021–2031 ($ MILLION)
TABLE 94.FRANCE CLINICAL TRIAL PACKAGING MARKET, BY END USER, 2021–2031 ($ MILLION)
TABLE 95.UK CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE, 2021–2031 ($ MILLION)
TABLE 96.UK CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL, 2021–2031 ($ MILLION)
TABLE 97.UK CLINICAL TRIAL PACKAGING MARKET, BY END USER, 2021–2031 ($ MILLION)
TABLE 98.ITALY CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE, 2021–2031 ($ MILLION)
TABLE 99.ITALY CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL, 2021–2031 ($ MILLION)
TABLE 100.ITALY CLINICAL TRIAL PACKAGING MARKET, BY END USER, 2021–2031 ($ MILLION)
TABLE 101.REST OF EUROPE CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE, 2021–2031 ($ MILLION)
TABLE 102.REST OF EUROPE CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL, 2021–2031 ($ MILLION)
TABLE 103.REST OF EUROPE CLINICAL TRIAL PACKAGING MARKET, BY END USER, 2021–2031 ($ MILLION)
TABLE 104.ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE, 2021–2031 ($ MILLION)
TABLE 105.ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL, 2021–2031 ($ MILLION)
TABLE 106.ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET, BY END USER, 2021–2031 ($ MILLION)
TABLE 107.ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET, BY COUNTRY, 2021–2031 ($ MILLION)
TABLE 108.CHINA CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE, 2021–2031 ($ MILLION)
TABLE 109.CHINA CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL, 2021–2031 ($ MILLION)
TABLE 110.CHINA CLINICAL TRIAL PACKAGING MARKET, BY END USER, 2021–2031 ($ MILLION)
TABLE 111.JAPAN CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE, 2021–2031 ($ MILLION)
TABLE 112.JAPAN CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL, 2021–2031 ($ MILLION)
TABLE 113.JAPAN CLINICAL TRIAL PACKAGING MARKET, BY END USER, 2021–2031 ($ MILLION)
TABLE 114.SOUTH KOREA CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE, 2021–2031 ($ MILLION)
TABLE 115.SOUTH KOREA CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL, 2021–2031 ($ MILLION)
TABLE 116.SOUTH KOREA CLINICAL TRIAL PACKAGING MARKET, BY END USER, 2021–2031 ($ MILLION)
TABLE 117.INDIA CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE, 2021–2031 ($ MILLION)
TABLE 118.INDIA CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL, 2021–2031 ($ MILLION)
TABLE 119.INDIA CLINICAL TRIAL PACKAGING MARKET, BY END USER, 2021–2031 ($ MILLION)
TABLE 120.REST OF ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE, 2021–2031 ($ MILLION)
TABLE 121.REST OF ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL, 2021–2031 ($ MILLION)
TABLE 122.REST OF ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET, BY END USER, 2021–2031 ($ MILLION)
TABLE 123.LAMEA CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE, 2021–2031 ($ MILLION)
TABLE 124.LAMEA CLINICAL TRIAL PACKAGING MARKET, BY WATER FED, 2021–2031 ($ MILLION)
TABLE 125.LAMEA CLINICAL TRIAL PACKAGING MARKET, BY END USER, 2021–2031 ($ MILLION)
TABLE 126.LAMEA CLINICAL TRIAL PACKAGING MARKET, BY COUNTRY, 2021–2031 ($ MILLION)
TABLE 127.LATIN AMERICA CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE, 2021–2031 ($ MILLION)
TABLE 128.LATIN AMERICA CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL, 2021–2031 ($ MILLION)
TABLE 129.LATIN AMERICA CLINICAL TRIAL PACKAGING MARKET, BY END USER, 2021–2031 ($ MILLION)
TABLE 130.MIDDLE EAST CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE, 2021–2031 ($ MILLION)
TABLE 131.MIDDLE EAST CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL, 2021–2031 ($ MILLION)
TABLE 132.MIDDLE EAST CLINICAL TRIAL PACKAGING MARKET, BY END USER, 2021–2031 ($ MILLION)
TABLE 133.AFRICA CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE, 2021–2031 ($ MILLION)
TABLE 134.AFRICA CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL, 2021–2031 ($ MILLION)
TABLE 135.AFRICA CLINICAL TRIAL PACKAGING MARKET, BY APPLICATION, 2021–2031 ($ MILLION)
TABLE 136.3M COMPANY: KEY EXECUTIVES
TABLE 137.3M COMPANY: COMPANY SNAPSHOT
TABLE 138.3M COMPANY: OPERATING BUSINESS SEGMENTS
TABLE 139.3M COMPANY: R&D EXPENDITURE, 2019-2021
TABLE 140.3M COMPANY: NET SALES, 2019-2021
TABLE 141.3M COMPANY- KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 142.ALMAC GROUP LTD: KEY EXECUTIVES
TABLE 143.ALMAC GROUP LTD: COMPANY SNAPSHOT
TABLE 144.ALMAC GROUP LTD: OPERATING BUSINESS CATEGORY
TABLE 145.ALMAC GROUP LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 146.BILCARE LIMITED: KEY EXECUTIVES
TABLE 147.BILCARE LIMITED: COMPANY SNAPSHOT
TABLE 148.BILCARE LIMITED: PRODUCT PORTFOLIO
TABLE 149.BILCARE LIMITED: R&D EXPENDITURE, 2021
TABLE 150.BILCARE LIMITED: NET SALES, 20219-2021
TABLE 151.CALIGOR COGHLAN: KEY EXECUTIVES
TABLE 152.CALIGOR COGHLAN: COMPANY SNAPSHOT
TABLE 153.CALIGOR COGHLAN: PRODUCT PORTFOLIO
TABLE 154.CALIGOR COGHLAN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 155.CORDEN PHARMA INTERNATIONAL: KEY EXECUTIVES
TABLE 156.CORDEN PHARMA INTERNATIONAL: COMPANY SNAPSHOT
TABLE 157.CORDEN PHARMA INTERNATIONAL: OPERATING BUSINESS CATEGORIES
TABLE 158.CORDEN PHARMA INTERNATIONAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 159.KOERBER MEDIPAK SYSTEMS AG: KEY EXECUTIVES
TABLE 160.KOERBER MEDIPAK SYSTEMS AG: COMPANY SNAPSHOT
TABLE 161.KOERBER MEDIPAK SYSTEMS AG: OPERATING BUSINESS CATEGORY
TABLE 162.KOERBER MEDIPAK SYSTEMS AG : KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 163.MAWDSLEY-BROOKS & CO. LTD.: KEY EXECUTIVES
TABLE 164.MAWDSLEY-BROOKS & CO. LTD.: COMPANY SNAPSHOT
TABLE 165.MAWDSLEY-BROOKS & CO. LTD.: OPERATING BUSINESS CATEGORIES
TABLE 166.MAWDSLEY-BROOKS & CO. LTD.-: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 167.NEXTPHARMA TECHNOLOGIES HOLDING LTD- KEY EXECUTIVES
TABLE 168.NEXTPHARMA TECHNOLOGIES HOLDING LIMITED- OPERATING BUSINESS CATEGORIES
TABLE 169.NEXTPHARMA TECHNOLOGIES HOLDING LIMITED- KEY STRATEGIES AND DEVELOPMENTS
TABLE 170.PAREXEL INTERNATIONAL CORPORATION- KEY EXECUTIVES
TABLE 171.PAREXEL INTERNATIONAL CORPORATION- COMPANY SNAPSHOT
TABLE 172.PAREXEL INTERNATIONAL CORPORATION- PRODUCT PORTFOLIO
TABLE 173.PAREXEL INTERNATIONAL CORPORATION- KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 174.PCI PHARMA SERVICES- KEY EXECUTIVES
TABLE 175.PCI PHARMA SERVICES : COMPANY SNAPSHOT
TABLE 176.PCI PHARMA SERVICES- OPERATING BUSINESS CATEGORIES
TABLE 177.PCI PHARMA SERVICES- KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 178.PIRAMAL ENTERPRISES LTD.- KEY EXECUTIVES
TABLE 179.PIRAMAL ENTERPRISES LTD.- COMPANY SNAPSHOT
TABLE 180.PIRAMAL ENTERPRISES LTD.- OPERATING BUSINESS SEGMENTS
TABLE 181.PIRAMAL ENTERPRISES LTD.: NET SALES, 2019-2021
TABLE 182.PIRAMAL ENTERPRISES LTD.- KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 183.SENTRY BIOPHARMA SERVICES, INC-KEY EXECUTIVES
TABLE 184.SENTRY BIOPHARMA SERVICES- COMPANY SNAPSHOT
TABLE 185.SENTRY BIOPHARMA SERVICES- PRODUCT PORTFOLIO
TABLE 186.SHARP SERVICES, LLC- KEY EXECUTIVES
TABLE 187.SHARP SERVICES, LLC- COMPANY SNAPSHOT
TABLE 188.SHARP SERVICES, LLC- OPERATING BUSINESS CATEGORIES
TABLE 189.SHARP SERVICES, LLC- PRODUCT PORTFOLIO
TABLE 190.THERMO FISHER SCIENTIFIC INC.- KEY EXECUTIVES
TABLE 191.THERMO FISHER SCIENTIFIC INC.- COMPANY SNAPSHOT
TABLE 192.THERMO FISHER SCIENTIFIC INC.- OPERATING BUSINESS SEGMENTS
TABLE 193.THERMO FISHER SCIENTIFIC INC.- PRODUCT PORTFOLIO
TABLE 194.THERMO FISHER SCIENTIFIC INC.: NET SALES, 2019-2021
TABLE 195.WESTROCK COMPANY- KEY EXECUTIVES
TABLE 196.WESTROCK COMPANY- COMPANY SNAPSHOT
TABLE 197.WESTROCK COMPANY- OPERATING BUSINESS CATEGORY
TABLE 198.WESTROCK COMPANY- KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 199.WUXI APPTEC- KEY EXECUTIVES
TABLE 200.WUXIAPPTEC- COMPANY SNAPSHOT
TABLE 201.WUXI APPTEC- OPERATING BUSINESS CATEGORY
TABLE 202.WUXI APPTEC- KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 203.XERIMIS INC- KEY EXECUTIVES
TABLE 204.XERIMIS INC- COMPANY SNAPSHOT
TABLE 205.XERIMIS INC OPERATES ITS BUSINESS THROUGH THE FOLLOWING BUSINESS CATEGORIES
TABLE 206.XERIMIS INC.- KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 01.KEY MARKET SEGMENTS
FIGURE 02.CLINICAL TRIAL PACKAGING SNAPSHOT, FOR SEGMENT, 2021–2031
FIGURE 03.CLINICAL TRIAL PACKAGING SNAPSHOT, BY COUNTRY, 2021–2031
FIGURE 04.CLINICAL TRIAL PACKAGING: KEY PLAYERS
FIGURE 05.TOP INVESTMENT POCKETS
FIGURE 06.TOP INVESTMENT FACTOR
FIGURE 08.PARENT MARKET ANALYSIS
FIGURE 09.LOW-TO-MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 10.LOW-TO-HIGH THREAT OF NEW ENTRANTS
FIGURE 11.LOW-TO-HIGH THREAT OF SUBSTITUTES
FIGURE 12.MODERATE BARGAINING POWER OF BUYERS
FIGURE 13.MODERATE INTENSITY OF RIVALRY
FIGURE 14.VALUE CHAIN ANALYSIS
FIGURE 15.SMILING CURVE VALUE CHAIN MODEL
FIGURE 16.PRODUCT LIFE-CYCLE ANALYSIS
FIGURE 17.MARKET DYNAMICS
FIGURE 18.CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE, 2021–2031
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF CLINICAL TRIAL PACKAGING MARKET FOR SYRINGES, BY COUNTRY, 2021 & 2031 (%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF CLINICAL TRIAL PACKAGING MARKET FOR VIALS & AMPOULES, BY COUNTRY, 2021 & 2031 (%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF CLINICAL TRIAL PACKAGING MARKET FOR BOTTLES, BY COUNTRY, 2021 & 2031 (%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF CLINICAL TRIAL PACKAGING MARKET FOR BAGS & POUCHES, BY COUNTRY, 2021 & 2031 (%)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF CLINICAL TRIAL PACKAGING MARKET FOR OTHERS, BY COUNTRY, 2021 & 2031 (%)
FIGURE 24.CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL, 2021–2031
FIGURE 25.COMPARATIVE SHARE ANALYSIS OF CLINICAL TRIAL PACKAGING MARKET FOR PLASTIC, BY COUNTRY, 2021 & 2031 (%)
FIGURE 26.COMPARATIVE SHARE ANALYSIS OF CLINICAL TRIAL PACKAGING MARKET FOR GLASS, BY COUNTRY, 2021 & 2031 (%)
FIGURE 27.COMPARATIVE SHARE ANALYSIS OF CLINICAL TRIAL PACKAGING MARKET FOR METAL, BY COUNTRY, 2021 & 2031 (%)
FIGURE 28.COMPARATIVE SHARE ANALYSIS OF CLINICAL TRIAL PACKAGING MARKET FOR PAPER, BY COUNTRY, 2021 & 2031 (%)
FIGURE 29.COMPARATIVE SHARE ANALYSIS OF CLINICAL TRIAL PACKAGING MARKET FOR CORRUGATED FIBER, BY COUNTRY, 2021 & 2031 (%)
FIGURE 30.CLINICAL TRIAL PACKAGING MARKET, BY END USER, 2021–2031
FIGURE 31.COMPARATIVE SHARE ANALYSIS OF CLINICAL TRIAL PACKAGING MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2021 & 2031 (%)
FIGURE 32.COMPARATIVE SHARE ANALYSIS OF CLINICAL TRIAL PACKAGING MARKET FOR CLINICAL RESEARCH ORGANIZATIONS, BY COUNTRY, 2021 & 2031 (%)
FIGURE 33.COMPARATIVE SHARE ANALYSIS OF CLINICAL TRIAL PACKAGING MARKET DRUG MANUFACTURING FACILITIES, BY COUNTRY, 2021 & 2031 (%)
FIGURE 34.CLINICAL TRIAL PACKAGING MARKET, BY REGION, 2021–2031
FIGURE 35.U.S. CLINICAL TRIAL PACKAGING MARKET REVENUE, 2021–2031 ($ MILLION)
FIGURE 36.CANADA CLINICAL TRIAL PACKAGING MARKET REVENUE, 2021–2031 ($ MILLION)
FIGURE 37.MEXICO CLINICAL TRIAL PACKAGING MARKET REVENUE, 2021–2031 ($ MILLION)
FIGURE 38.GERMANY CLINICAL TRIAL PACKAGING MARKET REVENUE, 2021–2031 ($ MILLION)
FIGURE 39.FRANCE CLINICAL TRIAL PACKAGING MARKET REVENUE, 2021–2031 ($ MILLION)
FIGURE 40.UK CLINICAL TRIAL PACKAGING MARKET REVENUE, 2021–2031 ($ MILLION)
FIGURE 41.ITALY CLINICAL TRIAL PACKAGING MARKET REVENUE, 2021–2031 ($ MILLION)
FIGURE 42.REST OF EUROPE CLINICAL TRIAL PACKAGING MARKET REVENUE, 2021–2031 ($ MILLION)
FIGURE 43.CHINA CLINICAL TRIAL PACKAGING MARKET REVENUE, 2021–2031 ($ MILLION)
FIGURE 44.JAPAN CLINICAL TRIAL PACKAGING MARKET REVENUE, 2021–2031 ($ MILLION)
FIGURE 45.SOUTH KOREA CLINICAL TRIAL PACKAGING MARKET REVENUE, 2021–2031 ($ MILLION)
FIGURE 46.INDIA CLINICAL TRIAL PACKAGING MARKET REVENUE, 2021–2031 ($ MILLION)
FIGURE 47.REST OF ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET REVENUE, 2021–2031 ($ MILLION)
FIGURE 48.LATIN AMERICA CLINICAL TRIAL PACKAGING MARKET REVENUE, 2021–2031 ($ MILLION)
FIGURE 49.MIDDLE EAST CLINICAL TRIAL PACKAGING MARKET REVENUE, 2021–2031 ($ MILLION)
FIGURE 50.AFRICA CLINICAL TRIAL PACKAGING MARKET REVENUE, 2021–2031 ($ MILLION)
FIGURE 51.MARKET PLAYER POSITIONING
FIGURE 52.TOP WINNING STRATEGIES, BY YEAR, 2020–2022
FIGURE 53.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020–2022 (%)
FIGURE 54.TOP WINNING STRATEGIES, BY COMPANY, 2020–2022
FIGURE 55.COMPANY SNAPSHOT-1
FIGURE 56.3M COMPANY: R&D EXPENDITURE, 2019-2021
FIGURE 57.3M COMPANY: NET SALES, 2019-2021
FIGURE 58.3M COMPANY: REVENUE SHARE BY SEGMENT, 2021
FIGURE 59.3M COMPANY: REVENUE SHARE BY REGION, 2021
FIGURE 60.BILCARE LIMITED: R&D EXPENDITURE, 2021
FIGURE 61.BILCARE LIMITED: NET SALES, 2019-2021
FIGURE 62.BILCARE LIMITED: REVENUE SHARE BY REGION
FIGURE 63.PIRAMAL ENTERPRISES LTD.: NET SALES, 2019-2021
FIGURE 64.PIRAMAL ENTERPRISES LTD.: REVENUE SHARE BY SEGMENT, 2021
FIGURE 65.THERMO FISHER SCIENTIFIC INC.: NET SALES, 20219-2021
FIGURE 66.THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE BY SEGMENT
FIGURE 67.THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE BY REGION